Ultrasound

In addition to significantly reduced interpretation time, researchers found that adjunctive AI with ultrasound resulted in accuracy improvements of greater than 7 percent for nodule echogenicity and 16 percent for nodule margin assessments.

In comparison to LI-RADS version 2018 for MRI assessment, the use of perfluorobutane-enhanced ultrasound incorporating Kupffer-phase findings yielded comparable sensitivity and specificity for detecting hepatocellular carcinoma (HCC) nodules < 20 mm in high-risk patients, according to new research.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Catch up on a variety of new FDA clearances in radiology from the past week.

In a prospective comparison with prior criteria for evaluating hepatocellular carcinoma surveillance, the American Association for the Study of Liver Diseases (AASLD) version 2023 system offered significantly higher sensitivity.

Catch up on a variety of new FDA clearances in radiology from the past week.

Offering an echogenic cutting cannula and enhanced sampling capability, the EnCor EnCompass Breast Biopsy and Tissue Removal System reportedly enables biopsy procedures across different breast imaging platforms.

Offering compact versatility for an array of clinical settings, the ASUS Handheld Ultrasound LU800 is reportedly the first handheld device to be supported across Android, Chrome, iOS and Windows operating systems.

The Echo Stewardship Program, which allows non-sonographer clinicians to perform focused cardiac ultrasound exams under physician guidance, is now cleared for use across handheld, laptop and cart-based ultrasound platforms

In a new literature review, researchers discuss common patterns and complications with cosmetic fillers that can be revealed on ultrasound imaging.

Catch up on the most well-viewed radiology content from 2025.

Catch up on the most well-viewed ultrasound content from 2025.

Catch up on the top radiology content of the past week.

Preliminary research has shown that the Vanquish Water Vapor Ablation System eliminated MRI-visible intermediate-risk PCa in over 90 percent of patients.

The recently launched PIV Assist reportedly offers a variety of features including real-time calculation of the catheter-to-vein ratio and pre-scan differentiation of veins and arteries to facilitate vascular access planning.

The newly launched Compass AI software platform reportedly facilitates a 94 percent compliance rate for documentation of point-of-care ultrasound (POCUS) exams.

The Sonosite MT ultrasound device reportedly combines portability and enhanced high-resolution images with multiple features to promote workflow efficiency.

Ultrasound-derived fat fraction assessment offered higher AUCs for differentiating mild, moderate and severe hepatic steatosis in comparison to established noninvasive measures of metabolic dysfunction-associated steatosis liver disease (MASLD), according to new multicenter research.

Already in use in multiple countries, the Pulsenmore ES ultrasound platform reportedly enables expectant mothers to transmit ultrasound video clips through a smartphone app for remote interpretation.

The Paradise Ultrasound Renal Denervation System has demonstrated efficacy and a favorable safety profile in randomized controlled trials for the treatment of mild, moderate and resistant hypertension.

Offering real-time, high-resolution ultrasound imaging for a range of procedures, the zero-capex Intracardiac Imaging System reportedly facilitates workflow efficiencies and reduced costs.

Designed for use in saline contrast echocardiography, the ASI-02 modality is currently being evaluated in a multicenter, randomized trial for patients undergoing transthoracic echocardiography (TTE).

In a recent interview, Deepa Sheth, M.D., discussed the rising incidence of breast cancer, key considerations in supplemental imaging for women with dense breasts and use of the CIVIE RadPod platform to facilitate consistent quality and imaging reads by fellowship-trained breast radiologists.

New enhancements for the Venue POCUS devices include automated labeling of anatomical landmarks with Nerveblox to facilitate 12 common peripheral nerve blocks and contrast-enhanced ultrasound geared to abdominal injury assessments.

The AI-powered Viz ACS platform may facilitate improved communication between clinicians and more rapid treatment for cases involving acute coronary syndrome.